Syncona Limited (SYNC) Ordinary NPV

- Add to watchlist
- Create an alert
- This stock can be held in a




News, reports & tips
-
Syncona firm Beacon reports encouraging gene therapy trial results
7 May 2025 11:36
(Sharecast News) - Syncona said in an update on Wednesday that its portfolio company Beacon Therapeutics has reported encouraging six-month interim results from its phase two 'DAWN' trial, marking...
-
London close: Stocks mixed in quiet post-Christmas trade
27 December 2024 14:38
(Sharecast News) - London markets closed on a mixed note Friday in subdued trading, as the ongoing holiday period kept activity light with little news to influence sentiment.
-
Syncona investment sells cancer study assets to AstraZeneca for $12m
27 December 2024 07:03
(Sharecast News) - Life science investor Syncona said its investment Achilles Therapeutics has sold cancer study assets to AstraZeneca for $12m (£9.58m).
-
Syncona upbeat on interim trial results at Beacon Therapeutics
6 December 2024 14:55
(Sharecast News) - Syncona announced positive three-month interim results from the phase two 'DAWN' trial conducted by its portfolio company Beacon Therapeutics on Friday.
-
Syncona launches Slingshot platform with £12.5m investment
14 November 2024 11:34
(Sharecast News) - Syncona announced the launch of Slingshot Therapeutics, a new portfolio company and accelerator dedicated to developing early-stage life science programs sourced from academia, on Thursday.
-
Syncona's Autolus gets FDA approval for leukaemia treatment
11 November 2024 07:17
(Sharecast News) - Life science investor Syncona announced on Monday that its portfolio company Autolus Therapeutics has received US Food and Drug Administration (FDA) approval for Aucatzyl (obe-cel), a CAR...
-
Syncona's Purespring raises £80m in new financing
9 October 2024 07:21
(Sharecast News) - Life science investor Syncona said its portfolio company Purespring Therapeutics, which focuses on gene therapies for kidney diseases, had raised £80m in an oversubscribed financing.
-
Syncona commits £63.5m to Resolution Therapies
3 October 2024 12:14
(Sharecast News) - Syncona announced on Thursday that it has committed £63.5m in series B financing to Resolution Therapeutics, a portfolio company focused on macrophage therapy for inflammatory and...
-
Syncona confident in portfolio despite fall in NAV
13 August 2024 11:57
(Sharecast News) - Life science investor Syncona reported significant developments in its portfolio during its first quarter on Tuesday, despite a slight decline in net assets.
-
Syncona adds two oncology investments to portfolio
20 June 2024 12:11
(Sharecast News) - Life science investor Syncona announced the addition of two new oncology companies to its portfolio on Thursday.
-
Syncona reports positive findings from investee Freeline
9 May 2024 11:19
(Sharecast News) - Life science investor Syncona reported positive findings from its portfolio company Freeline Therapeutics on Thursday, after a phase one and two study of its gene therapy candidate for...
-
Syncona NAV grows in Q3
8 February 2024 09:04
(Sharecast News) - Life sciences investor Syncona said on Thursday that its net asset value had grown in the three months ended 31 December, driven by a prioritisation of capital allocation across its...
Company announcements Announcements
-
Transaction in Own Shares
16 May 2025 07:00
Syncona Limited NPV
-
Spur presents new data
15 May 2025 11:15
Syncona Limited NPV
-
Transaction in Own Shares
15 May 2025 07:00
Syncona Limited NPV
-
Transaction in Own Shares
14 May 2025 07:00
Syncona Limited NPV
-
Transaction in Own Shares
13 May 2025 07:00
Syncona Limited NPV
-
Transaction in Own Shares
12 May 2025 07:00
Syncona Limited NPV
-
Transaction in Own Shares
9 May 2025 07:00
Syncona Limited NPV
-
Autolus reports Q1 2025 Financial Results
8 May 2025 16:30
Syncona Limited NPV
-
Transaction in Own Shares
8 May 2025 07:00
Syncona Limited NPV
-
Transaction in Own Shares
7 May 2025 07:00
Syncona Limited NPV
-
Beacon presents positive data
7 May 2025 07:00
Syncona Limited NPV
-
Transaction in Own Shares
6 May 2025 07:00
Syncona Limited NPV
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.